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ABSTRACT 
 
Background: Clinical trial registration is proposed to mitigate selective reporting in scientific research. 
It remains unknown whether trial registration is associated with reported outcomes in physiotherapy 
trials.  
 
Aims: To analyse the association between trial registration status and reported outcomes for 
physiotherapy RCTs.  
 
Methods:  All RCTs reporting a physiotherapy intervention, published in PubMed between 1st January 
2017 and 30th June 2017, were included. Trial registration was determined based on the reporting of 
a registration number in the primary paper or by identifying trials through trial registry databases.  
 
Findings: Of the 291 trials analysed, 176 (61%) were registered; 115 (40%) were not. There was no 
significant association between trial registration and outcome on multivariate analyses (OR: 1.65; 95% 
CI: 0.92 to 2.96; p=0.09). Only 22% of trials were prospectively registered.  
 
Conclusions: Registration status and trial outcome are not associated in physiotherapy RCTs. The 
frequency of registration of physiotherapy trials remains low.  
 
Keywords: Clinical trial; reporting; rehabilitation; outcomes; trial methodology 
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KEY POINTS 
1. Trial registration is inconsistently undertaken in physiotherapy randomised controlled trials. 
2. Outcome of trials reported does not appear to be related to them being registered or not. 
3. There was no significant association between reported outcome and timing of registration 
(prospective versus retrospective). 
4. Further support is required to increase trial registration in physiotherapy research to 
improve reporting rigor. 
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INTRODUCTION 
 
Clinical trials constitute the most robust source of research to underpin evidence-based practice in 
healthcare (Howick et al. 2009). Despite the advantages conferred by appropriate randomised 
controlled trial (RCT) designs for minimising bias in individual studies, the value of this evidence to 
clinical practice can be undermined by other sources of bias. These include selective trial reporting, 
which may arise from researchers not submitting their work for peer-review or publishers not 
accepting a research report (De Angelis et al. 2004; Costa et al. 2013).  
To address this issue of selective outcome reporting, the International Committee of Medical Journal 
Editors (ICMJE) mandated prospective trial registration as a prerequisite for publishing clinical trial 
reports (De Angelis et al. 2004). This initiative was followed by a similar recommendation from the 
International Society of Physiotherapy Journal Editors (ISPJE) in 2013 (Costa et al. 2013). The Food 
and Drug Administration Amendments Act of 2007 (FDAAA) even places a legal obligation on 
sponsors and investigators to register certain clinical trials of FDA-regulated biologics, drugs and 
devices prospectively on ClinicalTrials.gov (Zarin et al. 2016). 
Trial registration offers transparency to other researchers and the public (to avoid duplicating 
research efforts, highlight opportunities for further research and permit quality improvement), exists 
as a record to hold investigators accountable to their original research aims, and eventually captures 
data – regardless of their impact – on outcomes that might otherwise go unreported.  
Despite the implementation of large-scale projects to reduce reporting bias, cross-sectional 
investigations of published RCTs have revealed incomplete uptake and mixed approaches to trial 
registration since the release of the ICMJE statement in 2004 (Costa et al. 2013). Babu et al. (2014) 
reported that only 29% of English articles reported trial registration in MEDLINE-indexed ISPJE 
journals. More recently, an investigation of trials dual-registered on the websites ClinicalTrials.gov 
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and EU Clinical Trials Register (EUCTR) also identified discrepancies in the completion statuses of 
16% of 10,492 trials (Fleminger and Goldacre 2018).  
Epidemiological studies have previously assessed the association between trial registration status 
and outcome (the rejection or acceptance of a primary null hypothesis) without an overarching 
consensus (Rasmussen et al. 2009; Emdin et al. 2015; Dechartres et al. 2016; Odutayo et al. 2017). If 
the results of a trial are found to be independently associated with its registration status, this may 
constitute another variable that stakeholders in healthcare and publishing need to consider when 
appraising RCTs.  
 
Physiotherapy practice has become increasingly evidence-based (Kerry 2017) with the assistance of 
improved RCT quality/quantity (Kelly et al. 2018), and the discipline is considered an important and 
cost-effective component of the national health infrastructure of many countries, including the NHS 
in the United Kingdom (NHS England 2019). Modern physiotherapy’s perceived utility – from the 
perspectives of commissioners, practitioners and the public – is therefore guided by the scientific 
method and susceptible to biases in reporting. 
 
No study has evaluated whether trial registration status (an item of best practice in reporting) and 
trial outcome (the indicator of physiotherapy’s utility) – two notionally independent variables – are 
linked in physiotherapy research. Therefore, this study aimed to determine the nature of this 
relationship in a large sample of recently published physiotherapy RCTs, while simultaneously 
providing demographic data on recent registration practice in this field. Based on the existing trends 
in the literature, we hypothesised that trials registered on a publicly available database would be 
less likely to report a positive primary outcome than trials that are unregistered. 
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METHODS 
 
 
Trial identification  
A literature search for RCTs where physiotherapy was a trial intervention (control or experimental) 
was conducted using the PubMed database on 18th November 2017. PubMed was selected because 
it ranks amongst the most comprehensive databases for physiotherapy research (Michaleff et al. 
2011). All eligible trials published between 1st January 2017 and 30th June 2017 were included. The 
search terms are presented in Supplementary File 1. 
 
Trials were included if they reported an RCT (including feasibility/pilot RCTs) pertinent to 
physiotherapy practice in human subjects. Trials were excluded if any of the following applied: were 
secondary analyses of an RCT; non-RCT design; no control group; the topic was deemed not to be 
directly relevant to physiotherapy; the full-text was unavailable in English; viewpoint, protocol, 
outcome validation or qualitative report; or the paper was a follow-up to multiple RCTs with 
potentially differing original registration characteristics.  
 
All search strategy titles and abstracts were independently reviewed against the eligibility criteria by 
two reviewers (CE-B, HK). Citations deemed potentially eligible were independently assessed in full-
text papers by the same reviewers to determine final inclusion. Any disagreement was adjudicated 
by a third reviewer (TS).  
 
Data extraction 
Data were extracted from each included trial independently by two reviewers (CE-B, HK) with 
disagreements resolved through adjudication by a third reviewer (TS). For follow-up RCTs that did 
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not contain, but rather cited, full details of the methods used, the referenced article was consulted 
to extract appropriate trial characteristics. 
 
a. Trial characteristics 
 
The following data were extracted: research funding (industry-funded, non-industry-funded or 
having unknown funding sources); the type (clinical, university, residential, other, multiple types or 
unclear) and number (single-centre, multicentre, or unknown number) of study centres; country and 
continent of origin; sample size; reporting of an a priori sample size calculation; reporting of random 
sequence generation and allocation concealment based on the Cochrane Collaboration’s Risk of Bias 
criteria (Higgins and Green 2011); blinding (single-blind, double-blind, no blinding, unclear blinding); 
reporting of participant numbers/attrition at trial end (with reasons for any dropouts; without 
reasons; not reported); journal name; trial registration status and reported outcomes.  
 
b. Registration status 
 
Registration status was ascertained from the trial registry record for each trial. Where the trial 
registration number was specified, the record was accessed and the presented trial dates and topic 
were cross-referenced with the published paper. Where no trial registration number was specified, 
the international trial registries EUCTR, the World Health Organisation International Clinical Trials 
Registry Platform (WHO ICTRP), ClinicalTrials.gov, and the International Standard Randomised 
Controlled Trial Number (ISRCTN) were searched using the surname of the first author and keywords 
for the article topic. This approach has been previously recommended (Glanville et al. 2014; Odutayo 
et al. 2017). If the study could not be found in a trial registry, it was classified as unregistered.  
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A trial was classified as prospectively registered when the listed registration date preceded or was 
no more than one month later than the date of first participant enrolment. When registered later 
than this point, it was classified as retrospectively registered. 
 
c. Trial outcome 
 
A significant outcome was attributed when the primary outcome was reported as statistically 
significant (p<0.05) and/or an effect estimate with a confidence interval (CI) that excluded the value 
of no effect, for the intervention group relative to at least one control group. If the null hypothesis 
could not be rejected, the trial was attributed as having a null outcome. For non-inferiority trials, the 
rejection of the null hypothesis entailed no statistical difference between the two assessed 
treatments (Mallat 2017). Where the results included per-protocol and intention-to-treat analyses, 
rejection of the null hypothesis by either analysis led to classification of the trial as significant. 
Where a primary outcome was not explicitly defined, the outcome discussed most prominently was 
considered the primary outcome.  
 
Quality assurance 
Quality assurance assessments were conducted for a random selection of approximately 10% (n=22) 
of the trial data extraction forms. This reported a reliability of 91%. Consistent discrepancies in data 
extraction were discussed and concordance established between the two reviewers (CE-B, HK) prior 
to continuing the remaining data extraction.   
 
Data analysis 
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A power calculation was used to determine the sample size based on a significance level (alpha) of 
5% and power (1-β) of 90%, where the percentage of registered studies was 61% and unregistered 
was 39%. This indicated that a minimum of 208 studies would be required. 
 
Univariate analyses were performed for all study variables with trial outcome as the response 
variable. Discrete and continuous variables were analysed using a chi-squared test and ANOVA, 
respectively. Significance was set at p<0.10 for the univariate analyses to detect factors that 
correlate with trial outcome (for use in the multivariate analysis) with greater sensitivity.  
 
Logistic regression was adopted with the independent variables comprising those determined to be 
significant in the univariate analysis and with trial outcome remaining the response (dependent) 
variable. Regression analyses were presented as odds ratios and 95% confidence intervals (CIs). A 
p<0.05 was deemed statistically significant.  
 
Exploratory univariate (chi-squared) analyses of the association between trial outcome and 
registration status were also performed with registration status stratified alternatively. The first 
exploratory analysis excluded unregistered trials, comparing prospectively registered trials with 
retrospectively registered trials. The second exploratory analysis grouped retrospectively registered 
and unregistered trials and compared these with prospectively registered trials.  
 
All analyses were conducted on IBM SPSS Statistics version 25.0 (IBM, New York, USA). 
 
 
RESULTS 
 
Search strategy 
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The results of the search strategy and number of included trials is illustrated in Supplementary File 
2. In brief, from 630 potentially eligible titles, 323 met the eligibility criteria and were included.  
 
Characteristics of included trials 
The characteristics of the included trials are summarised in Table 1. The journals in which they were 
published are presented in Supplementary File 3. In brief, of the 323 trials, 71 trials (22%) were 
prospectively registered and 122 (38%) were retrospectively registered; 130 trials (40%) being 
unregistered. The number of trials with a significant outcome was 215 (67%), null outcome was 76 
(24%) and unclear outcome was 32 (10%). The frequency of trials by outcome when assessed by 
country of origin is presented in Supplementary File 4. 
 
Association between outcome and registration status 
The univariate analysis of associations between trial outcome and the other trial variables of interest 
revealed significant (p<0.10) interactions for registration status (p=0.03), funding source (p=0.03), 
country of origin (p=0.04), and large sample size (p=0.10) (Table 2). Specifically, trials were more 
likely to report a significant outcome if they were unregistered (versus registered), non-industry-
funded or lacking in funding details (versus industry-funded) or small (N<99) in initial sample size. 
Although significant, the precise relationship between the country of a study’s origin and trial 
outcome is unclear based on the described analysis alone.  
 
The results for the multivariate analysis of the interaction between these trial characteristics and 
trial outcome are shown in Table 3. No association was detected between trial outcome and the 
variables tested in the multivariate analysis, including registration status (OR: 1.65; 95% CI: 0.92 to 
2.96; p=0.09).  
 
Secondary exploratory analyses 
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There was no association between registration status and reported outcome when trials were 
grouped as prospectively versus retrospectively registered (p=0.15; Table 4) or when grouped 
unregistered and retrospectively registered trials versus prospectively registered (p=0.69). 
 
DISCUSSION 
 
This study has shown, for the first time, that there is no statistical association between registration 
status (or any other variable) and trial outcome for physiotherapy RCTs (p=0.09). However, the 
significant association between registration status and study outcome identified in the primary 
univariate analysis (p=0.03) described an inverse relationship between trial registration and 
significant outcome reporting.  
 
The lack of any significant association according to the multivariate analysis (Table 3) suggests that 
trial outcome is not significantly influenced by any single investigated variable, including registration 
status, in recently published physiotherapy RCTs. Instead, trial registration status, funding source, 
country of origin and sample size appear (altogether or in part) to collinearly influence trial outcome; 
the extent of this collinearity has not been specifically confirmed, as it is beyond the scope of this 
study. The exclusion of an independent association between trial registration and outcome is a 
significant and encouraging finding for physiotherapy as a discipline, due to its aforementioned role 
in national healthcare (NHS England 2019) and growing reliance on evidence from trials to inform 
clinical practice (Scurlock-Evans et al. 2014; Kerry 2017).  
 
Despite the lack of an association through the multivariate analysis, it is clear from the result of the 
univariate analyses and other statistical observations that reporting practice in physiotherapy 
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research requires improvement. More than one-third of the included trials were unregistered even 
at the time of article publication. Prospective registration of only 22% of included papers also 
suggests that adherence to the specific ICMJE, ISPJE and Declaration of Helsinki recommendations is 
not widespread (De Angelis et al. 2004; World Medical Association 2008; Costa et al. 2013). This 
prospective registration figure falls slightly short of that of 31% identified by Harriman and Patel 
(2016) in a search of all clinical trials published in the BMC series in 2013. Such figures provide 
further impetus to encourage protocol registration as mandatory for all clinical trials. 
 
Of the registered trials that passed the screening process for this study, 37% were registered 
prospectively and 63% retrospectively. This contrasts with the findings of Hunter et al. (2018) in their 
descriptive review of interventional trials registered on Australian New Zealand Clinical Trials 
Register (ANZCTR). They reported that, since 2012, 64% of registered trials were filed prospectively. 
This indicates that adherence to prospective trial registration standards among physiotherapy trials 
falls considerably below that for clinical trials more generally. Such figures provide evidence that 
further measures to enforce prospective physiotherapy trial registration are required. 
 
According to the univariate analysis, the results of which are shown in Table 2, trials appeared more 
likely to report a positive outcome if they were (1) non-industry-funded or lacking in funding details, 
(2) small (≤99) in initial sample size, or (3) unregistered; possible reasons for these findings will be 
discussed briefly. It is probable that other variables (not extracted in this study) would also have 
shown an association with trial outcome. Future cross-sectional studies might benefit from assessing 
overall trial quality during the data extraction process using a validated measure, such as the 
Physiotherapy Evidence Database (PEDro) rating scale, to offer a potentially useful variable to test 
for an association with trial outcome or registration likelihood (Maher et al. 2003; de Morton 2009). 
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The association found for non-industry-funded research contrasts interestingly with observations in 
drug and medical device (Lundh et al. 2017) and “nondrug” (Bhandari et al. 2004) trials that industry-
sponsored trials tend to favour the sponsor’s product/intervention. It cannot be excluded that this 
difference is due to the small number of industry-funded studies (and/or poor reporting of funding 
sources among industry-funded trials) herein leading to a type I error (falsely positive): When articles 
reporting industry funding and unclear funding are pooled together, the proportion of pooled trials 
with a positive outcome rises to 68.5% (versus 77.2% for non-industry-funded trials). Additionally, 
the possibility of not-for-profit organisations with undisclosed for-profit support indirectly or directly 
influencing trial design/findings should be borne in mind (Hakoum et al. 2017). 
 
Trials with an initial sample size of more than 99 participants were found to be less likely to report a 
positive outcome (66.2%) than those with fewer (76.2%). Clearly, the appropriate minimum sample 
size will differ between studies, depending on effect size. However, this finding is consistent with an 
increase in the likelihood of obtaining a type I error (falsely positive) or type II error (falsely negative 
– rendering the finding less likely to be published and thus outside the content of interest in this 
study) if the sample size is smaller rather than larger (Hackshaw 2008). Furthermore, larger studies  
might have improved prospects of publication if they present negative findings through having 
greater power (Weller 2002). 
 
The most obvious implication of the univariate association between positive trial outcome and a lack 
of trial registration is that trial registration functions in some way to reduce selective outcome 
reporting. The mechanism by which this occurs may include the publicly available registry inducing 
researchers both to publish their findings in a form that corresponds to the capabilities of their 
prespecified methods and to avoid negative attention from publishers by omitting or reprioritising 
prespecified study outcomes (Emdin et al. 2015). However, it is likely that this is not the complete 
picture, given that that the two exploratory univariate analyses identified no association between 
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registration status and trial outcome (p=0.151 and p=0.693; Table 4). Further work to identify the 
cause of this apparent discrepancy is clearly warranted and might include assessing the agreement 
between registry outcomes and reported outcomes in practice.  
 
This analysis presented three important limitations. Firstly, only papers published in English were 
included, and these may not be representative of the wider field of physiotherapy publishing 
practice. Secondly, there is considerable subjectivity in defining and specifically selecting 
‘physiotherapy’ trials, which was mitigated to an extent by an inclusive approach and through 
discussion between the three reviewers. Thirdly, a significant result was determined by statistical 
significance only, and it is acknowledged that a statistically significant outcome does not necessarily 
equate to a clinically significant outcome.   
 
CONCLUSIONS 
 
This study demonstrates that there is no statistical association between trial registration status 
(registered versus unregistered) and primary study outcome (positive versus negative) among 
physiotherapy trials when accounting for funding source, initial sample size and country of origin in a 
multivariate analysis. This study has also identified incomplete and mixed registration practice 
among physiotherapy RCTs, with low adherence (22%) to widespread recommendations for 
prospective registration. Resolution of these issues will improve the completeness and integrity of 
the scientific record, minimisation of reporting bias and growth of robust clinical evidence.  
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FIGURE AND TABLE LEGENDS 
 
 
Table 1. Demographic characteristics of the included randomised controlled trials. 
 
Table 2. Primary univariate analysis of the association between trial characteristics and trial 
outcome, excluding trials with an unclear primary outcome and without stratifying registration as 
prospective or retrospective. 
 
Table 3. Primary multivariate analysis (multinomial logistic regression) of the association between 
trial characteristics (established to be significant in the univariate analysis) and primary trial 
outcome. 
 
Table 4. Exploratory univariate (chi-squared) analyses of the association between trial registration 
status and outcome with alternative stratification by registration status.  
 
 
 
Supplementary File 1: Search terms used on PubMed. 
 
Supplementary File 2: Flow diagram of articles through the screening processes.  
Supplementary File 3: Table illustrating the journals where the 323 included papers were published. 
Supplementary File 4: Table illustrating the country of origin for each included trial and the 
frequency of significant, null and unclear outcomes per country. 
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Table 1: Demographic characteristics of the 323 included randomised controlled trials. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Study characteristic Number and 
percentage of papers 
Registration status Prospectively registered 71 (22%) 
Retrospectively registered 122 (37.8%) 
Unregistered 130 (40.2%) 
Primary outcome Significant 215 (66.6%) 
Null 76 (23.5%) 
Unclear 32 (9.9%) 
Funding source Industry 30 (9.3%) 
Non-industry 205 (63.5%) 
Unclear 88 (27.2%) 
Continent of origin Asia 69 (21.4%) 
Africa 1 (0.3%) 
North America 61 (18.9%) 
South America 39 (12.1%) 
Europe 134 (41.5%) 
Australia and Oceania 19 (5.9%) 
Number of centres Single 225 (69.7%) 
Multiple 38 (11.8%) 
Unclear 60 (18.6%) 
Setting type Clinical 125 (38.7%) 
University 60 (18.6%) 
Residential 23 (7.1%) 
Other 14 (4.3%) 
Multiple 46 (14.2%) 
Unclear 55 (17%) 
Initial sample size > 99 Yes 74 (22.9%) 
No 249 (77.1%) 
Sample size calculations 
described 
Yes 174 (53.9%) 
No 149 (46.1%) 
Adequate random 
sequence generation 
described 
Yes 201 (62.2%) 
No 122 (37.8%) 
Adequate allocation 
concealment described 
Yes 112 (34.7%) 
No 211 (65.3%) 
Blinding Single 135 (41.8%) 
Double 42 (13%) 
None  50 (15.5%) 
Unclear 96 (29.7%) 
Attrition described Yes, details provided 251 (77.7%) 
Yes, no details provided 29 (9%) 
No 43 (13.3%) 
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Table 2: Primary univariate analysis of the association between trial characteristics and trial 
outcome, excluding trials with an unclear primary outcome and without stratifying registration as 
prospective or retrospective. 
 
Study characteristic Articles with 
a significant 
outcome 
Articles with 
a null 
outcome 
P value* 
Registration status 
Registered 122 (69.3%) 54 (30.7%) 
0.028 
Unregistered 93 (80.9%) 22 (19.1%) 
Funding source 
Industry 15 (53.6%) 13 (46.4%) 
0.03 Non-industry 139 (77.2%) 41 (22.8%) 
Unclear 61 (73.5%) 22 (26.5%) 
Country of origin** 0.042 
Continent of origin** 0.306 
Number of centres 
Single 150 (74.3%) 52 (25.7%) 
0.208 Multiple 22 (62.9%) 13 (37.1%) 
Unclear 43 (79.6%) 11 (20.4%) 
Setting type 
Clinical 85 (76.6%) 26 (23.4%) 
0.952 
University 38 (70.4%) 16 (29.6%) 
Residential 16 (72.7%) 6 (27.3%) 
Other 9 (69.2%) 4 (30.8%) 
Multiple 30 (71.4%) 12 (28.6%) 
Unclear 37 (75.5%) 12 (24.5%) 
Initial sample size (#) 0.133 
Initial sample size > 99 
Yes 45 (66.2%) 23 (33.8%) 
0.098 
No 170 (76.2%) 53 (23.8%) 
Journal** 0.587 
Sample size calculations 
described 
Yes 110 (71.0%) 45 (29.0%) 
0.227 
No 105 (77.2%) 31 (22.8%) 
Adequate random 
sequence generation 
described 
Yes 135 (72.2%) 52 (27.8%) 
0.379 No 80 (77.0%)  24 (23.0%) 
Adequate allocation 
concealment described 
Yes 71 (68.9%) 32 (31.1%) 
0.155 
No 144 (76.6%) 44 (23.4%) 
Blinding 
Single 91 (73.4%) 33 (26.6%) 
0.782 
Double 31 (77.5%) 9 (22.5%) 
None  28 (68.3%) 13 (31.7%) 
Unclear 65 (75.6%) 21 (24.4%) 
Attrition described 
Yes, details 
provided 
162 (72%) 63 (28%) 
0.149 Yes, no details 
provided 
20 (71.4%) 8 (28.6%) 
No 33 (86.8%) 5 (13.2%) 
*Determined with outcome as the response variable, using ANOVA for “Initial sample size (#)” and a 
chi-squared test for the remaining variables. For this univariate analysis, significance was determined 
as p<0.10. **Data on these variables are presented in the Appendix (Sections 2 and 3). 
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Table 3: Primary multivariate analysis (multinomial logistic regression) of the association between 
trial characteristics (established to be significant in the univariate analysis) and primary trial 
outcome. 
 
Study characteristic Odd Ratio 
(95% CI) 
P value* 
Registration status 1.65 (0.92-2.96) 0.094 
Funding source 1.22 (0.77-1.94) 0.406 
Country of origin 1.01 (0.99-1.03) 0.352 
Initial sample size 
(Large/Small) 
1.54 (0.84-2.81) 0.165 
*For this multinomial logistic regression, significance was determined as p<0.05.  
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Table 4: Exploratory univariate (chi-squared) analyses of the association between trial registration 
status and outcome with alternative stratification by registration status.  
 
Study characteristic Articles with a 
significant outcome  
Articles with a 
null outcome 
P value 
First 
exploratory 
analysis 
Prospectively 
registered 
50 (75.8%) 16 (24.2%) 0.151 
Retrospectively 
registered 
72 (65.5%) 38 (34.5%) 
Second 
exploratory 
analysis 
Prospectively 
registered 
50 (75.8%) 16 (24.2%) 0.693 
Retrospectively 
registered and 
unregistered 
165 (73.3%) 60 (26.7%) 
 
 
 
